IFP Advisors’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 5330 |
|
|
2026
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 5209 |
|
|
2025
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 5080 |
|
|
2025
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 4986 |
|
|
2025
Q2 | $0 | Buy |
+200
| New | – | ﹤0.01% | 5080 |
|
|
2023
Q1 | – | Sell |
-18
| Closed | -$8K | – | 4703 |
|
|
2022
Q4 | $8K | Hold |
18
| – | – | ﹤0.01% | 3575 |
|
|
2022
Q3 | $8K | Hold |
18
| – | – | ﹤0.01% | 3827 |
|
|
2022
Q2 | $8K | Hold |
18
| – | – | ﹤0.01% | 3573 |
|
|
2022
Q1 | $8K | Buy |
+18
| New | +$8K | ﹤0.01% | 3572 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$7K | – | 4017 |
|
|
2018
Q4 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 2734 |
|
|
2018
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 3031 |
|
|
2018
Q2 | $7K | Sell |
1,000
-1,000
| -50% | -$7.87K | ﹤0.01% | 3136 |
|
|
2018
Q1 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 2549 |
|
|
2017
Q4 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 2585 |
|
|
2017
Q3 | $14K | Hold |
2,000
| – | – | ﹤0.01% | 2861 |
|
|
2017
Q2 | $14K | Buy |
2,000
+1,000
| +100% | +$5.48K | ﹤0.01% | 2835 |
|
|
2017
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3256 |
|
|
2016
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3257 |
|
|
2016
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3196 |
|
|
2016
Q2 | $6K | Buy |
+1,000
| New | +$6.13K | ﹤0.01% | 3113 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$6K | – | 4559 |
|
|
2015
Q4 | $6K | Buy |
+1,000
| New | +$5.38K | ﹤0.01% | 2930 |
|
Other funds holding SVA
IFP Advisors's SVA Position: Q2 2026 in Review
IFP Advisors held its Sinovac Biotech, Ltd (SVA) position steady in Q2 2026 at 200 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5330.
IFP Advisors first reported a position in SVA in Q4 2015 and has held it in 21 quarters since. The position peaked at $16K in Q1 2018. 2 funds tracked by Wall St. Rank hold SVA as of Q2 2026.
- IFP Advisors held 200 shares of Sinovac Biotech, Ltd worth $0 as of Q2 2026.
- IFP Advisors left its Sinovac Biotech, Ltd share count unchanged in Q2 2026.
- Sinovac Biotech, Ltd made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5330 holding.
- IFP Advisors first reported a position in Sinovac Biotech, Ltd in Q4 2015 and has held it in 21 quarters since.
- IFP Advisors's Sinovac Biotech, Ltd position peaked at $16K in Q1 2018.
- 2 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.